Finding into death of Ryan Andrew Robinson
Deceased
Ryan Andrew Robinson
Demographics
31y, male
Date of death
2023-05-17
Finding date
2025-08-21
Cause of death
Mixed drug toxicity (heroin, bromazolam, metonitazine, protonitazene, methamphetamine, oxycodone, dextromethorphan, clonazepam, nitrazepam)
AI-generated summary
Ryan Robinson, a 31-year-old man with longstanding opioid use disorder and complex mental health conditions, died from mixed drug toxicity involving heroin, novel psychoactive substances (nitazenes: metonitazene and protonitazene; bromazolam), benzodiazepines, methamphetamine, and prescription opioids. His GP Dr D. provided appropriate, evidence-based care including methadone substitution, specialist referrals, and careful oxycodone tapering completed in 2022. Ryan's death resulted from unknown substances obtained from unregulated markets—the coroner found no clinical care deficiencies. The finding emphasizes harm reduction through Victoria's newly implemented Pill Testing Service, highlighting how drug checking can identify dangerous synthetic opioids and enable informed decision-making.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
Drugs involved
Contributing factors
- Use of novel psychoactive substances from unregulated drug markets
- Concurrent use of multiple CNS depressants and stimulants enhancing respiratory depression risk
- Inability to determine composition of illicit substances obtained from unregulated markets
- Longstanding opioid use disorder with recurrent relapse cycles
- Complex comorbid mental health conditions including PTSD, depression, anxiety
Coroner's recommendations
- Continued operation and expansion of Victoria's Pill Testing Service as a critical harm reduction initiative to detect life-threatening substances and enable informed decision-making
- Sustained public health messaging about the dangers of obtaining substances from unregulated drug markets and the unpredictable nature of novel psychoactive substances
- Continued monitoring of novel psychoactive substance trends in Victoria to inform public health and harm reduction strategies
- Support for drug harm reduction organisations, addiction medicine experts, and public health initiatives addressing opioid overdose mortality
Full text
Related cases
Source and disclaimer
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —